-
1.发明授权Method for customized dispensing of variable dose drug combination products for individualizing of therapies 有权用于定制分配用于个体化治疗的可变剂量药物组合产品的方法公开(公告)号：US08022032B2
公开(公告)日：2011-09-20
申请号：US11718154
申请日：2005-11-18
CPC分类号： A61K9/2095 , A23L33/30 , A61K9/2072 , A61K9/209 , A61K45/06 , Y02A90/26
摘要： The method set out herein involves identifying the concentration of each of two or more active therapeutics tailored to treat a particular patient's unique metabolism and one or more diseases, communicating that information to a producer who has multiple fixed or variable concentrations of each active available, where the producer then combines the individual concentrations of each active into single units such as a tablets or pills, and distributes those indirectly or directly to the patient.
摘要翻译： 本文提出的方法涉及确定为治疗特定患者的独特代谢和一种或多种疾病而定制的两种或多种活性治疗剂中的每一种的浓度，将该信息传递给具有多种固定或可变浓度的每种可用活性的生产者，其中 然后生产者将每个活性物质的单个浓度合并成单个单位如片剂或丸剂，并间接地或直接地将它们分配给患者。
-
2.发明申请METHOD FOR CUSTOMIZED DISPENSING OF VARIABLE DOSE DRUG COMBINATION PRODUCTS FOR INDIVIDUALIZING OF THERAPIES 有权用于个体化治疗的可变剂量药物组合产品的定制分配方法公开(公告)号：US20120029030A1
公开(公告)日：2012-02-02
申请号：US13197486
申请日：2011-08-03
IPC分类号： A61K31/4439 , A61K31/351 , A61P3/10 , A61K31/40
CPC分类号： A61K9/2095 , A23L33/30 , A61K9/2072 , A61K9/209 , A61K45/06 , Y02A90/26
摘要： Generally the method involves identifying the concentration of each of two or more active therapeutics tailored to treat a particular patient's unique metabolism and one or more diseases, communicating that information to a producer who has multiple fixed or variable concentrations of each active available, where the producer then combines the individual concentrations of each active into single units such as a tablets or pills, and distributes those indirectly or directly to the patient.
摘要翻译： 通常，该方法包括确定为治疗特定患者的唯一代谢和一种或多种疾病而定制的两种或更多种活性治疗剂中的每一种的浓度，将该信息传达给具有多种固定或可变浓度的每种可用活性的生产者，其中生产者 然后将每个活性物质的单个浓度合并成单个单位如片剂或丸剂，并间接地或直接地将其分配给患者。
-
3.发明授权Method for customized dispensing of variable dose drug combination products for individualizing of therapies 有权用于定制分配用于个体化治疗的可变剂量药物组合产品的方法公开(公告)号：US08383579B2
公开(公告)日：2013-02-26
申请号：US13197486
申请日：2011-08-03
CPC分类号： A61K9/2095 , A23L33/30 , A61K9/2072 , A61K9/209 , A61K45/06 , Y02A90/26
摘要： Generally the method involves identifying the concentration of each of two or more active therapeutics tailored to treat a particular patient's unique metabolism and one or more diseases, communicating that information to a producer who has multiple fixed or variable concentrations of each active available, where the producer then combines the individual concentrations of each active into single units such as a tablets or pills, and distributes those indirectly or directly to the patient.
摘要翻译： 通常，该方法包括确定为治疗特定患者的唯一代谢和一种或多种疾病而定制的两种或更多种活性治疗剂中的每一种的浓度，将该信息传达给具有多种固定或可变浓度的每种可用活性的生产者，其中生产者 然后将每个活性物质的单个浓度合并成单个单位如片剂或丸剂，并间接地或直接地将其分配给患者。
-
4.发明申请METHOD FOR CUSTOMIZED DISPENSING OF VARIABLE DOSE DRUG COMBINATION PRODUCTS FOR INDIVIDUALIZING OF THERAPIES 有权用于个体化治疗的可变剂量药物组合产品的定制分配方法公开(公告)号：US20090149507A1
公开(公告)日：2009-06-11
申请号：US11718154
申请日：2005-11-18
IPC分类号： A61K31/40 , A61K31/4439 , A61K31/351 , A61K31/35
CPC分类号： A61K9/2095 , A23L33/30 , A61K9/2072 , A61K9/209 , A61K45/06 , Y02A90/26
摘要： The method set out herein involves identifying the concentration of each of two or more active therapeutics tailored to treat a particular patient's unique metabolism and one or more diseases, communicating that information to a producer who has multiple fixed or variable concentrations of each active available, where the producer then combines the individual concentrations of each active into single units such as a tablets or pills, and distributes those indirectly or directly to the patient.
摘要翻译： 本文提出的方法涉及确定为治疗特定患者的独特代谢和一种或多种疾病而定制的两种或多种活性治疗剂中的每一种的浓度，将该信息传递给具有多种固定或可变浓度的每种可用活性的生产者，其中 然后生产者将每个活性物质的单个浓度合并成单个单位如片剂或丸剂，并间接地或直接地将它们分配给患者。
-
公开(公告)号：US4831018A
公开(公告)日：1989-05-16
申请号：US030008
申请日：1987-03-25
申请人： Richard L. Kirsh , Louis J. Ravin
发明人： Richard L. Kirsh , Louis J. Ravin
CPC分类号： A61K31/70 , A61K9/1075 , C07H17/08 , Y10S514/938 , Y10S514/943
摘要： A polyene antibiotic emulsion formulation comprising a therapeutically effective amount of the antibiotic incorporated into an oil-in-water emulsion, and a method of treating an active infection in an animal caused by a microorganism with sterols in its cell membrane by parenterally administering the emulsion formulation to such animal.
摘要翻译： 包含治疗有效量的掺入到水包油乳剂中的抗生素的多烯抗生素乳液制剂，以及通过肠胃外施用所述乳液制剂治疗由其细胞膜中的甾醇引起的动物引起的动物活性感染的方法 到这样的动物。
-
公开(公告)号：US4707470A
公开(公告)日：1987-11-17
申请号：US735492
申请日：1985-05-17
申请人： Richard L. Kirsh , Louis J. Ravin
发明人： Richard L. Kirsh , Louis J. Ravin
IPC分类号： A61K31/54 , A61K9/107 , A61K31/70 , A61P31/04 , C07H17/08 , A61K47/00 , A61K31/17 , A61K31/18 , A61K31/57
CPC分类号： A61K31/70 , A61K9/1075 , C07H17/08 , Y10S514/938 , Y10S514/943
摘要： A polyene antibiotic emulsion formulation comprising a therapeutically effective amount of the antibiotic incorporated into an oil-in-water emulsion, and a method of treating an active infection in an animal caused by a microorganism with sterols in its cell membrane by parenterally administering the emulsion formulation to such animal.
摘要翻译： 包含治疗有效量的掺入到水包油乳剂中的抗生素的多烯抗生素乳液制剂，以及通过肠胃外施用所述乳液制剂治疗由其细胞膜中的甾醇引起的动物引起的动物活性感染的方法 到这样的动物。
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.024 秒)
